ONYX PHARMACEUTICALS INC: current_liabilities
| Value | {"amount": 114775000, "concept": "us-gaap:LiabilitiesCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2012-09-30) |
| Status | current |
| Entity | ONYX PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:49:46.140887+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/aae19fb2-93d3-4714-8cb5-160bdfdcbd18
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-12-073762 · Open the official SEC filing →Retrieved: 2026-08-19T09:49:46.140887+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001012140/current-liabilities/2012-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/aae19fb2-93d3-4714-8cb5-160bdfdcbd18
History
- no predecessors — first report